FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
“These findings potentially support employing anti-aging therapies such as senolytic pharmacologic compounds to prevent or ameliorate progression to AMD [...]” “This matter is, therefore, critical for ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...
Scientists headed by a team at Tel Aviv University have combined a map of gene regulatory sites with disease-associated loci to uncover a new genetic risk factor for age-related macular degeneration ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, No. 21 (May 25, 2021), pp. 1-12 (12 pages) Loss of the retinal pigment epithelium (RPE) because of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results